BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer · HER2-positive Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Illinois, Chicago, Illinois, United States
Contact: Study coordinator (Kent Hoskins, MD) · khoski@uic.ed · 312-355-0496
Contact: Study coordinator (Mercedes Carrasquillo, BS) · micarras@uic.edu · 3124131902

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Breast Cancer · Quality of Life

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.

Breast Cancer

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

Breast Cancer

Abroad (travel likely)Recruiting

Chapel Hill, United States